Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
01/2013
01/29/2013US8361983 Therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumors
01/29/2013US8361982 Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
01/29/2013US8361981 Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
01/29/2013US8361979 Means and method for inducing exon-skipping
01/29/2013US8361977 Compositions and methods for modulation of SMN2 splicing
01/29/2013US8361976 Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules
01/29/2013US8361933 Polypeptide display libraries and methods of making and using thereof
01/29/2013US8361787 Method for expression of small RNA molecules within a cell
01/29/2013US8361777 Genes for biosynthesis of tetracycline compounds and uses thereof
01/29/2013US8361773 Polynucleotides encoding polypeptides and host cells therefor
01/29/2013US8361767 BGL7 beta-glucosidase and nucleic acids encoding the same
01/29/2013US8361761 Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
01/29/2013US8361756 Bifidobacterial gene sequences and their use
01/29/2013US8361755 Compositions and methods for grain processing without pH adjustment
01/29/2013US8361754 Recombinant reverse transcriptases
01/29/2013US8361747 Antibodies against human angiopoietin 2
01/29/2013US8361727 3′OH-unblocked, nucleotides and nucleosides base modified with labels and photocleavable, terminating groups and methods for their use in DNA sequencing
01/29/2013US8361723 Keratin 8 mutations are risk factors for developing liver disease of multiple etiologies
01/29/2013US8361719 Methods for quantitative determination of methylation density in a DNA locus
01/29/2013US8361718 Methods for nucleic acid manipulation
01/29/2013US8361717 Magnetic particles for nucleic acid sequencing and method of sequencing nucleic acid using the same
01/29/2013US8361713 System and apparatus for sequential processing of analytes
01/29/2013US8361711 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances
01/29/2013US8361710 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-21
01/29/2013US8361708 Human virus causing severe acute respiratory syndrome (SARS) and uses thereof
01/29/2013US8361510 Nanogels for cellular delivery of therapeutics
01/29/2013US8361478 Recombinant viral-based malaria vaccines
01/29/2013US8361474 Anti-IL-12 antibody based vectors, host cells, and methods of production and uses
01/29/2013US8361462 Anti-apoptotic protein antibodies
01/29/2013CA2677781C Nitrilases
01/29/2013CA2489360C Methods and compositions for determining methylation profiles
01/29/2013CA2482995C Low-cost production of peptides
01/29/2013CA2477975C Novel vip3 toxins and methods of use
01/24/2013WO2013013068A2 Embodiments of a probe and method for targeting nucleic acids
01/24/2013WO2012138955A3 CONFORMATIONALLY-PREORGANIZED, MiniPEG-CONTAINING GAMMA-PEPTIDE NUCLEIC ACIDS
01/24/2013US20130025006 MODIFIED Cry1Ca INSECTICIAL Cry PROTEINS
01/24/2013US20130024953 Methods of Treating Disorders Associated with Protein Aggregation
01/24/2013US20130023655 Method for precipitating anionic surfactant ions in the presence of nucleic acids
01/24/2013US20130023579 Modulation of angiopoietin-like 3 expression
01/24/2013US20130023578 siRNA for inhibition of c-Met expression and anticancer composition containing the same
01/24/2013US20130023473 Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity
01/24/2013US20130023446 siRNA Targeting Beta Secretase (BACE)
01/24/2013US20130023442 Single nucleotide polymorphism for predicting recurrence of hepatocellular carcinoma
01/24/2013US20130023426 Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids
01/24/2013US20130023423 Transposon nucleic acids comprising a calibration sequence for dna sequencing
01/24/2013US20130023030 Recovery of recombinant human parainfluenza virus type 2 (hypiv2) from cdna and use of recombinant hpiv2 in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens
01/24/2013US20130022983 Colon and Rectal Tumor Markers and Methods of Use Thereof
01/24/2013US20130022980 Rna- and dna-copying enzymes
01/24/2013US20130022975 Method for detecting arteriosclerotic diseases on the basis of single nucleotide polymorphism at human chromosome 5p15.3
01/24/2013US20130022876 Surface modified polymeric materials, modified functionalized polymers, functional polymers, and methods
01/24/2013US20130022669 Branched, compact polyethyleneglycol derivatives
01/24/2013US20130022667 Fidgetin-like 2 as a target to enhance wound healing
01/24/2013US20130022634 New composition and methods for treatment of autoimmune and allergic diseases
01/24/2013US20130022624 Anti-epidermal growth factor receptor antibodies and uses thereof
01/24/2013US20130022606 Neutralizing prolactin receptor antibodies and their therapeutic use
01/24/2013US20130022602 Methods and compositions to modulate antiviral and immune activity responses
01/24/2013US20130022593 Methods of diagnosing endometriosis
01/24/2013US20130022578 Methods and system for interfering with viability of bacteria and related compounds and compositions
01/24/2013US20130022538 Aptamer-mrna conjugates for targeted protein or peptide expression and methods for their use
01/24/2013CA2842358A1 Methods for the synthesis of functionalized nucleic acids
01/24/2013CA2842103A1 Embodiments of a probe and method for targeting nucleic acids
01/23/2013EP2547809A1 Methods, probe sets, and kits for detection of deletion of tumor suppressor genes by fluorescence in situ hybridization
01/23/2013EP2547782A1 Methods, kits and compositions for detection of mrsa
01/23/2013EP2547781A1 Method of producing transcripts using cryptic splice sites
01/23/2013EP2547762A2 Light-sensitive ion-passing molecules
01/23/2013EP2547715A2 Cleavable modifications to reducible poly (amido ethylenimines)s to enhance nucleotide delivery
01/23/2013CN102892934A Methods, probe sets, and kits for detection of deletion of tumor suppressor genes by fluorescence in situ hybridization
01/23/2013CN102892809A Cleavable modifications to reducible poly (amido ethylenimines)s to enhance nucleotide delivery
01/23/2013CN102892420A Novel single chemical entities and methods for delivery of oligonucleotides
01/22/2013US8357844 Maize variety hybrid X8H573
01/22/2013US8357833 Corn plants and seed enhanced for asparagine and protein
01/22/2013US8357832 F1B-TMIR plasmid vector and transgenic mouse
01/22/2013US8357793 Label target and labeling reagents comprising backbones with at least two consecutive peptide bonds
01/22/2013US8357790 Phosphatidylinositol phosphate kinase type I gamma splice variants as biomarkers and drug targets for epithelial cancers
01/22/2013US8357789 comprising an RNA sequence capable of specifically binding a polypeptide participating in influenza virus infection of cells
01/22/2013US8357788 Thymidine kinase
01/22/2013US8357670 Oligomeric compounds for the modulation of HIF-1A expression
01/22/2013US8357669 Method of treatment for lymphedema comprising administering a polynucleotide encoding VEGF-D
01/22/2013US8357668 Compositions and methods for promoting wound healing and tissue regeneration
01/22/2013US8357666 Reprogramming a cell by inducing a pluripotent gene through RNA interference
01/22/2013US8357532 Expanding the eukaryotic genetic code
01/22/2013US8357515 Latency associated protein construct with aggrecanase sensitive cleavage site
01/22/2013US8357513 Nucleic acids encoding mpl ligand (thrombopoietin) and fragments thereof
01/22/2013US8357512 Systems for the expression of orthogonal translation components in eubacterial host cells
01/22/2013US8357503 Hydrolases, nucleic acids encoding them and methods for making and using them
01/22/2013US8357493 Method for detecting mycobacteria using deleted sequences in M. bovis BCG/M. bovis or tuberculosis
01/22/2013US8357488 Primers and probes for the detection of streptococcus pneumoniae
01/22/2013CA2692552C Novel protein isolated from pleurotus cornucopiae
01/22/2013CA2536735C Methods for determining cd8+ t-cell epitopes
01/22/2013CA2509337C Process for purification of plasmid dna
01/22/2013CA2477519C Method of error reduction in nucleic acid populations
01/22/2013CA2465158C Molecular detection systems utilizing reiterative oligonucleotide synthesis
01/17/2013WO2012162613A3 Detection of sequence variants in the human epidermal growth factor receptor (egfr) gene
01/17/2013WO2012162165A3 Antibodies to 25-hydroxyvitamin d2 and d3 and uses thereof
01/17/2013WO2012135848A3 Melatonin-based treatment and diagnosis of bile duct disease
01/17/2013US20130019350 Methods and Compositions for Selecting Corn Plants Resistant to Diplodia Ear Rot
01/17/2013US20130019342 Polynucleotides encoding trehalose-6-phosphate phosphatase and methods of use thereof
01/17/2013US20130019334 Corn event mzdt09y
01/17/2013US20130018180 Crystals of human topoisomerase ii-dna binary complex, methods for preparing the same and uses thereof
01/17/2013US20130018173 Identifying Affinity-Matured Human Antibodies
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 899